{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:55:08Z","timestamp":1769511308797,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,27]]},"DOI":"10.7759\/cureus.57055","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T17:17:49Z","timestamp":1711559869000},"source":"Crossref","is-referenced-by-count":4,"title":["A Mini Literature Review of Probiotics: Transforming Gastrointestinal Health Through Evidence-Based Insights"],"prefix":"10.7759","author":[{"given":"Cara","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon P","family":"Fuego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina V","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul Y","family":"Rajesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres S","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad J","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.689958","article-title":"Utilizing probiotics for the prevention and treatment of gastrointestinal diseases","volume":"12","author":"Milner E","year":"2021","unstructured":"Milner E, Stevens B, An M, et al.. Utilizing probiotics for the prevention and treatment of gastrointestinal diseases. Front Microbiol. 2021, 12:689958. 10.3389\/fmicb.2021.689958","journal-title":"Front Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26196076","article-title":"Probiotics regulate gut microbiota: an effective method to improve immunity","volume":"26","author":"Wang X","year":"2021","unstructured":"Wang X, Zhang P, Zhang X. Probiotics regulate gut microbiota: an effective method to improve immunity. Molecules. 2021, 26:6076. 10.3390\/molecules26196076","journal-title":"Molecules"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.578386","article-title":"Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body","volume":"12","author":"Cristofori F","year":"2021","unstructured":"Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021, 12:578386. 10.3389\/fimmu.2021.578386","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.117","article-title":"Probiotics and the gut microbiota in intestinal health and disease","volume":"7","author":"Gareau MG","year":"2010","unstructured":"Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010, 7:503-14. 10.1038\/nrgastro.2010.117","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000516023","article-title":"Probiotics in gastrointestinal diseases: all that glitters is not gold","volume":"40","author":"Compare D","year":"2022","unstructured":"Compare D, Sgamato C, Nardone OM, Rocco A, Coccoli P, Laurenza C, Nardone G. Probiotics in gastrointestinal diseases: all that glitters is not gold. Dig Dis. 2022, 40:123-32. 10.1159\/000516023","journal-title":"Dig Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231154443","article-title":"Current understanding of antibiotic-associated dysbiosis and approaches for its management","volume":"10","author":"Kesavelu D","year":"2023","unstructured":"Kesavelu D, Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis. 2023, 10:20499361231154443. 10.1177\/20499361231154443","journal-title":"Ther Adv Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Mearin F","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders. Gastroenterology. 2016, 150:1393-407.E5. 10.1053\/j.gastro.2016.02.031","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6110099","article-title":"Rome criteria and a diagnostic approach to irritable bowel syndrome","volume":"6","author":"Lacy BE","year":"2017","unstructured":"Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017, 6:99. 10.3390\/jcm6110099","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.014","article-title":"Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits","volume":"15","author":"Camilleri M","year":"2017","unstructured":"Camilleri M, Lembo A, Katzka DA. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin Gastroenterol Hepatol. 2017, 15:1338-49. 10.1016\/j.cgh.2017.05.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050587","article-title":"Cardiovascular toxicities associated with loperamide: analysis of the World Health Organization Pharmacovigilance database","volume":"143","author":"Ollitrault P","year":"2021","unstructured":"Ollitrault P, Dolladille C, Chr\u00e9tien B, Milliez P, Alexandre J. Cardiovascular toxicities associated with loperamide: analysis of the World Health Organization Pharmacovigilance database. Circulation. 2021, 143:403-5. 10.1161\/CIRCULATIONAHA.120.050587","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746585","article-title":"Lactobacillus plantarum CCFM1143 alleviates chronic diarrhea via inflammation regulation and gut microbiota modulation: a double-blind, randomized, placebo-controlled study","volume":"12","author":"Yang B","year":"2021","unstructured":"Yang B, Yue Y, Chen Y, et al.. Lactobacillus plantarum CCFM1143 alleviates chronic diarrhea via inflammation regulation and gut microbiota modulation: a double-blind, randomized, placebo-controlled study. Front Immunol. 2021, 12:746585. 10.3389\/fimmu.2021.746585","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.578089","article-title":"Do probiotics during in-hospital antibiotic treatment prevent colonization of gut microbiota with multi-drug-resistant bacteria? A randomized placebo-controlled trial comparing Saccharomyces to a mixture of Lactobacillus, Bifidobacterium, and Saccharomyces","volume":"8","author":"Wie\u00ebrs G","year":"2020","unstructured":"Wie\u00ebrs G, Verbelen V, Van Den Driessche M, Melnik E, Vanheule G, Marot JC, Cani PD. Do probiotics during in-hospital antibiotic treatment prevent colonization of gut microbiota with multi-drug-resistant bacteria? A randomized placebo-controlled trial comparing Saccharomyces to a mixture of Lactobacillus, Bifidobacterium, and Saccharomyces. Front Public Health. 2020, 8:578089. 10.3389\/fpubh.2020.578089","journal-title":"Front Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0788-9","article-title":"A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult\u00ae) in the management of diarrhea-predominant irritable bowel syndrome","volume":"18","author":"Ishaque SM","year":"2018","unstructured":"Ishaque SM, Khosruzzaman SM, Ahmed DS, Sah MP. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult\u00ae) in the management of diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 2018, 18:71. 10.1186\/s12876-018-0788-9","journal-title":"BMC Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2298246","article-title":"Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome","volume":"16","author":"Gargari G","year":"2024","unstructured":"Gargari G, Mantegazza G, Cremon C, et al.. Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome. Gut Microbes. 2024, 16:2298246. 10.1080\/19490976.2023.2298246","journal-title":"Gut Microbes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13456","article-title":"The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome","volume":"30","author":"Hod K","year":"2018","unstructured":"Hod K, Dekel R, Aviv Cohen N, et al.. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2018, 30:13456. 10.1111\/nmo.13456","journal-title":"Neurogastroenterol Motil"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-016-0140-6","article-title":"Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant irritable bowel syndrome: a double blind randomized placebo controlled pilot clinical study","volume":"15","author":"Majeed M","year":"2016","unstructured":"Majeed M, Nagabhushanam K, Natarajan S, et al.. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant irritable bowel syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr J. 2016, 15:21. 10.1186\/s12937-016-0140-6","journal-title":"Nutr J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.857","article-title":"Efficacy of diet restriction with or without probiotic for treatment of patients with IBS-D: phase I-II clinical trial","volume":"11","author":"Zhao XS","year":"2023","unstructured":"Zhao XS, Shi LJ, Ning BL, et al.. Efficacy of diet restriction with or without probiotic for treatment of patients with IBS-D: phase I-II clinical trial. Immun Inflamm Dis. 2023, 11:857. 10.1002\/iid3.857","journal-title":"Immun Inflamm Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.164","article-title":"Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis","volume":"106","author":"Suares NC","year":"2011","unstructured":"Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011, 106:1582-91; quiz 1581, 1592. 10.1038\/ajg.2011.164","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano A","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2015, 14:625-39. 10.1016\/S1474-4422(15)00007-1","journal-title":"Lancet Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2013.03.016","article-title":"Chronic constipation: a critical review","volume":"45","author":"Basilisco G","year":"2013","unstructured":"Basilisco G, Coletta M. Chronic constipation: a critical review. Dig Liver Dis. 2013, 45:886-93. 10.1016\/j.dld.2013.03.016","journal-title":"Dig Liver Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21243","article-title":"Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study","volume":"22","author":"Zangaglia R","year":"2007","unstructured":"Zangaglia R, Martignoni E, Glorioso M, et al.. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study. Mov Disord. 2007, 22:1239-44. 10.1002\/mds.21243","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182574f28","article-title":"Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease","volume":"78","author":"Ondo WG","year":"2012","unstructured":"Ondo WG, Kenney C, Sullivan K, et al.. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. Neurology. 2012, 78:1650-4. 10.1212\/WNL.0b013e3182574f28","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244680","article-title":"Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: a randomised controlled trial","volume":"15","author":"Ibrahim A","year":"2020","unstructured":"Ibrahim A, Ali RA, Manaf MR, et al.. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: a randomised controlled trial. PLoS One. 2020, 15:0244680. 10.1371\/journal.pone.0244680","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1412908","article-title":"Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a double-blind, randomized, placebo-controlled, and dose-ranging trial","volume":"9","author":"Ibarra A","year":"2018","unstructured":"Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018, 9:236-51. 10.1080\/19490976.2017.1412908","journal-title":"Gut Microbes"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12797","article-title":"Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial","volume":"20","author":"Martoni CJ","year":"2019","unstructured":"Martoni CJ, Evans M, Chow CT, Chan LS, Leyer G. Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial. J Dig Dis. 2019, 20:435-46. 10.1111\/1751-2980.12797","journal-title":"J Dig Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002028","article-title":"Usefulness of Bifidobacterium longum BB536 in elderly individuals with chronic constipation: a randomized controlled trial","volume":"118","author":"Takeda T","year":"2023","unstructured":"Takeda T, Asaoka D, Nojiri S, et al.. Usefulness of Bifidobacterium longum BB536 in elderly individuals with chronic constipation: a randomized controlled trial. Am J Gastroenterol. 2023, 118:561-8. 10.14309\/ajg.0000000000002028","journal-title":"Am J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-022-01189-0","article-title":"The effect of multistrain probiotics on functional constipation in the elderly: a randomized controlled trial","volume":"76","author":"\u0160ola KF","year":"2022","unstructured":"\u0160ola KF, Vladimir-Kne\u017eevi\u0107 S, Hraba\u010d P, Mucalo I, Saso L, Verbanac D. The effect of multistrain probiotics on functional constipation in the elderly: a randomized controlled trial. Eur J Clin Nutr. 2022, 76:1675-81. 10.1038\/s41430-022-01189-0","journal-title":"Eur J Clin Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znaa075","article-title":"Postoperative infection and mortality following elective surgery in the International Surgical Outcomes Study (ISOS)","volume":"108","author":"Wan YI","year":"2021","unstructured":"Wan YI, Patel A, Achary C, Hewson R, Phull M, Pearse RM. Postoperative infection and mortality following elective surgery in the International Surgical Outcomes Study (ISOS). Br J Surg. 2021, 108:220-7. 10.1093\/bjs\/znaa075","journal-title":"Br J Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2016.11.009","article-title":"Review of the mechanisms of probiotic actions in the prevention of colorectal cancer","volume":"37","author":"Dos Reis SA","year":"2017","unstructured":"Dos Reis SA, da Concei\u00e7\u00e3o LL, Siqueira NP, Rosa DD, da Silva LL, Peluzio MD. Review of the mechanisms of probiotic actions in the prevention of colorectal cancer. Nutr Res. 2017, 37:1-19. 10.1016\/j.nutres.2016.11.009","journal-title":"Nutr Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2019.73.316-320","article-title":"Usage of probiotics and its clinical significance at surgically treated patients sufferig from colorectal carcinoma","volume":"73","author":"Bajramagic S","year":"2019","unstructured":"Bajramagic S, Hodzic E, Mulabdic A, Holjan S, Smajlovic SV, Rovcanin A. Usage of probiotics and its clinical significance at surgically treated patients sufferig from colorectal carcinoma. Med Arch. 2019, 73:316-20. 10.5455\/medarh.2019.73.316-320","journal-title":"Med Arch"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1047-4","article-title":"A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer","volume":"19","author":"Zaharuddin L","year":"2019","unstructured":"Zaharuddin L, Mokhtar NM, Muhammad Nawawi KN, Raja Ali RA. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol. 2019, 19:131. 10.1186\/s12876-019-1047-4","journal-title":"BMC Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2015.07.010","article-title":"Effect of probiotics on postoperative quality of gastric bypass surgeries: a prospective randomized trial","volume":"12","author":"Chen JC","year":"2016","unstructured":"Chen JC, Lee WJ, Tsou JJ, Liu TP, Tsai PL. Effect of probiotics on postoperative quality of gastric bypass surgeries: a prospective randomized trial. Surg Obes Relat Dis. 2016, 12:57-61. 10.1016\/j.soard.2015.07.010","journal-title":"Surg Obes Relat Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202009_23059","article-title":"Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition - a double-blind, randomized, and placebo-controlled trial","volume":"24","author":"Ka\u017amierczak-Siedlecka K","year":"2020","unstructured":"Ka\u017amierczak-Siedlecka K, Folwarski M, Ruszkowski J, Skonieczna-\u017bydecka K, Szafra\u0144ski W, Makarewicz W. Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition - a double-blind, randomized, and placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2020, 24:9684-94. 10.26355\/eurrev_202009_23059","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.6133\/apjcn.202009_29(3).0004","article-title":"Does early postoperative enteral ecoimmunonutrition enhance intestinal function in gastric cancer?","volume":"29","author":"Xu R","year":"2020","unstructured":"Xu R, Xiao S, Ding Z, Zhao P. Does early postoperative enteral ecoimmunonutrition enhance intestinal function in gastric cancer?. Asia Pac J Clin Nutr. 2020, 29:469-75. 10.6133\/apjcn.202009_29(3).0004","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/0148607115584387","article-title":"Randomized clinical trial: Impact of oral administration of Saccharomyces boulardii on gene expression of intestinal cytokines in patients undergoing colon resection","volume":"40","author":"Consoli ML","year":"2016","unstructured":"Consoli ML, da Silva RS, Nicoli JR, Bru\u00f1a-Romero O, da Silva RG, de Vasconcelos Generoso S, Correia MI. Randomized clinical trial: Impact of oral administration of Saccharomyces boulardii on gene expression of intestinal cytokines in patients undergoing colon resection. JPEN J Parenter Enteral Nutr. 2016, 40:1114-21. 10.1177\/0148607115584387","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2016.044","article-title":"The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study","volume":"160","author":"Palumbo VD","year":"2016","unstructured":"Palumbo VD, Romeo M, Marino Gammazza A, et al.. The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016, 160:372-7. 10.5507\/bp.2016.044","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2018.18227","article-title":"Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial","volume":"30","author":"Y\u0131lmaz \u0130","year":"2019","unstructured":"Y\u0131lmaz \u0130, Dolar ME, \u00d6zp\u0131nar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. Turk J Gastroenterol. 2019, 30:242-53. 10.5152\/tjg.2018.18227","journal-title":"Turk J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky NA","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, et al.. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012, 142:46-54.e42; quiz e30. 10.1053\/j.gastro.2011.10.001","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-1056","article-title":"Effect of probiotics supplementation combined with WeChat platform health management on nutritional status, inflammatory factors, and quality of life in patients with mild-to-moderate ulcerative colitis: a randomized trial","volume":"10","author":"Ou Q","year":"2021","unstructured":"Ou Q, Wang L, Wang K, Shao P. Effect of probiotics supplementation combined with WeChat platform health management on nutritional status, inflammatory factors, and quality of life in patients with mild-to-moderate ulcerative colitis: a randomized trial. Ann Palliat Med. 2021, 10:6606-16. 10.21037\/apm-21-1056","journal-title":"Ann Palliat Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.01.010","article-title":"Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies","volume":"10","author":"Jess T","year":"2012","unstructured":"Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012, 10:639-45. 10.1016\/j.cgh.2012.01.010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref41","article-title":"[Probiotics\u2019 effectiveness on symptoms, histological features and feeding tolerance in ulcerative colitis]","volume":"57","author":"S\u00e1nchez-Morales A","year":"2019","unstructured":"S\u00e1nchez-Morales A, P\u00e9rez-Ayala MF, Cruz-Mart\u00ednez M, et al.. [Probiotics\u2019 effectiveness on symptoms, histological features and feeding tolerance in ulcerative colitis]. Rev Med Inst Mex Seguro Soc. 2019, 57:9-14.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2021.458","article-title":"Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis","volume":"37","author":"Park SK","year":"2022","unstructured":"Park SK, Kang SB, Kim S, et al.. Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis. Korean J Intern Med. 2022, 37:949-57. 10.3904\/kjim.2021.458","journal-title":"Korean J Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease","volume":"27","author":"Bjarnason I","year":"2019","unstructured":"Bjarnason I, Sission G, Hayee B. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. Inflammopharmacology. 2019, 27:465-73. 10.1007\/s10787-019-00595-4","journal-title":"Inflammopharmacology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-4946-2","article-title":"Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis","volume":"63","author":"Matsuoka K","year":"2018","unstructured":"Matsuoka K, Uemura Y, Kanai T, et al.. Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis. Dig Dis Sci. 2018, 63:1910-9. 10.1007\/s10620-018-4946-2","journal-title":"Dig Dis Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.805466","article-title":"Probiotics and functional gastrointestinal disorders in pediatric age: a narrative review","volume":"10","author":"Capozza M","year":"2022","unstructured":"Capozza M, Laforgia N, Rizzo V, Salvatore S, Guandalini S, Baldassarre M. Probiotics and functional gastrointestinal disorders in pediatric age: a narrative review. Front Pediatr. 2022, 10:805466. 10.3389\/fped.2022.805466","journal-title":"Front Pediatr"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/nu10020195","article-title":"Effectiveness and safety of a probiotic-mixture for the treatment of infantile colic: a double-blind, randomized, placebo-controlled clinical trial with fecal real-time PCR and NMR-based metabolomics analysis","volume":"10","author":"Baldassarre ME","year":"2018","unstructured":"Baldassarre ME, Di Mauro A, Tafuri S, et al.. Effectiveness and safety of a probiotic-mixture for the treatment of infantile colic: a double-blind, randomized, placebo-controlled clinical trial with fecal real-time PCR and NMR-based metabolomics analysis. Nutrients. 2018, 10:195. 10.3390\/nu10020195","journal-title":"Nutrients"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/nu8110677","article-title":"Administration of a multi-strain probiotic product to women in the perinatal period differentially affects the breast milk cytokine profile and may have beneficial effects on neonatal gastrointestinal functional symptoms. A randomized clinical trial","volume":"8","author":"Baldassarre ME","year":"2016","unstructured":"Baldassarre ME, Di Mauro A, Mastromarino P, et al.. Administration of a multi-strain probiotic product to women in the perinatal period differentially affects the breast milk cytokine profile and may have beneficial effects on neonatal gastrointestinal functional symptoms. A randomized clinical trial. Nutrients. 2016, 8:677. 10.3390\/nu8110677","journal-title":"Nutrients"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010225","article-title":"Lactobacillus reuteri DSM 17938 and magnesium oxide in children with functional chronic constipation: a double-blind and randomized clinical trial","volume":"12","author":"Kubota M","year":"2020","unstructured":"Kubota M, Ito K, Tomimoto K, et al.. Lactobacillus reuteri DSM 17938 and magnesium oxide in children with functional chronic constipation: a double-blind and randomized clinical trial. Nutrients. 2020, 12:225. 10.3390\/nu12010225","journal-title":"Nutrients"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0716-9","article-title":"Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study","volume":"45","author":"Cui X","year":"2019","unstructured":"Cui X, Shi Y, Gao S, Xue X, Fu J. Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study. Ital J Pediatr. 2019, 45:140. 10.1186\/s13052-019-0716-9","journal-title":"Ital J Pediatr"},{"key":"ref50","article-title":"Effect of a multi-strain probiotic on the incidence and severity of necrotizing enterocolitis and feeding intolerances in preterm neonates","volume":"14","author":"Sowden M","year":"2022","unstructured":"Sowden M, Weissenbruch MM, Bulabula AN, Wyk LV, Twisk J, Niekerk EV. Effect of a multi-strain probiotic on the incidence and severity of necrotizing enterocolitis and feeding intolerances in preterm neonates. Nutrients. 2022, 14:3305.","journal-title":"Nutrients"},{"key":"ref51","article-title":"Probiotics to prevent necrotising enterocolitis in very preterm infants","volume":"63","author":"Lamb\u00e6k ID","year":"2016","unstructured":"Lamb\u00e6k ID, Fonnest G, Gormsen M, Brok J, Greisen G. Probiotics to prevent necrotising enterocolitis in very preterm infants. Dan Med J. 2016, 63:5203.","journal-title":"Dan Med J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16308-3","article-title":"A randomized trial evaluating virus-specific effects of a combination probiotic in children with acute gastroenteritis","volume":"11","author":"Freedman SB","year":"2020","unstructured":"Freedman SB, Xie J, Nettel-Aguirre A, et al.. A randomized trial evaluating virus-specific effects of a combination probiotic in children with acute gastroenteritis. Nat Commun. 2020, 11:2533. 10.1038\/s41467-020-16308-3","journal-title":"Nat Commun"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/nu8100660","article-title":"Effect of Bifidobacterium breve on the intestinal microbiota of coeliac children on a gluten free diet: a pilot study","volume":"8","author":"Quagliariello A","year":"2016","unstructured":"Quagliariello A, Aloisio I, Bozzi Cionci N, et al.. Effect of Bifidobacterium breve on the intestinal microbiota of coeliac children on a gluten free diet: a pilot study. Nutrients. 2016, 8:660. 10.3390\/nu8100660","journal-title":"Nutrients"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1159\/000526712","article-title":"Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome: a pilot study","volume":"41","author":"Ait Abdellah S","year":"2023","unstructured":"Ait Abdellah S, Gal C, Laterza L, et al.. Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis. 2023, 41:489-99. 10.1159\/000526712","journal-title":"Dig Dis"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx254","article-title":"A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)","volume":"72","author":"Barker AK","year":"2017","unstructured":"Barker AK, Duster M, Valentine S, Hess T, Archbald-Pannone L, Guerrant R, Safdar N. A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO). J Antimicrob Chemother. 2017, 72:3177-80. 10.1093\/jac\/dkx254","journal-title":"J Antimicrob Chemother"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114516001665","article-title":"Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial","volume":"116","author":"Evans M","year":"2016","unstructured":"Evans M, Salewski RP, Christman MC, Girard SA, Tompkins TA. Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2016, 116:94-103. 10.1017\/S0007114516001665","journal-title":"Br J Nutr"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1078315","article-title":"Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy","volume":"12","author":"Labenz J","year":"2022","unstructured":"Labenz J, Borkenstein DP, Heil FJ, et al.. Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy. Front Oncol. 2022, 12:1078315. 10.3389\/fonc.2022.1078315","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238181-a-mini-literature-review-of-probiotics-transforming-gastrointestinal-health-through-evidence-based-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T17:18:00Z","timestamp":1711559880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238181-a-mini-literature-review-of-probiotics-transforming-gastrointestinal-health-through-evidence-based-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":57,"URL":"https:\/\/doi.org\/10.7759\/cureus.57055","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,27]]}}}